Ontology highlight
ABSTRACT:
SUBMITTER: Kesarwani M
PROVIDER: S-EPMC6945823 | biostudies-literature | 2019 Jan
REPOSITORIES: biostudies-literature
Kesarwani Meenu M Kincaid Zachary Z Azam Mohammad M
Journal of visualized experiments : JoVE 20190107 143
The demonstration of tyrosine kinase inhibitors (TKIs) in treating chronic myeloid leukemia (CML) has heralded a new era in cancer therapeutics. However, a small population of cells does not respond to TKI treatment, resulting in minimal residual disease (MRD); even the most potent TKIs fail to eradicate these cells. These MRD cells serve as a reservoir to develop resistance to therapy. Why TKI treatment is ineffective against MRD cells is not known. Growth factor signaling is implicated in supp ...[more]